Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1CEREZYME1件: Imiglucerase (Cerezyme)1件: Imiglucerase (Cerezyme (TN)) 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
2Cerezyme (imiglucerase for injection)1件: Imiglucerase (Cerezyme)1件: Imiglucerase (Cerezyme (TN)) 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
3Cerezyme 400 Units Powder for concentrate for solution for infusion1件: Imiglucerase (Cerezyme)1件: Imiglucerase (Cerezyme (TN)) 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
4Cerezyme®1件: Imiglucerase (Cerezyme)1件: Imiglucerase (Cerezyme (TN)) 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
5Cerezyme® / Imiglucerase1件: Imiglucerase (Cerezyme)1件: Imiglucerase (Cerezyme (TN)) 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
6EU-sourced Cerezyme1件: Imiglucerase (Cerezyme)1件: Imiglucerase (Cerezyme (TN)) 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
7IMIGLUCERASE
(Cerezyme (TN))		1件: Imiglucerase (Cerezyme)1件: Imiglucerase (Cerezyme (TN)) 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬